Enhancement of dissolution of Fenofibrate by solid dispersion technique

International Journal of Research in Pharmaceutical Sciences

Volumn 1, Issue 2, 2010, Pages 127-132

  Patel, Tejas ^a   Patel, L D ^b   Patel, Timir ^a   Makwana, Sunil ^a   Patel, Tushar ^a  

^a DHARMSINH DESAI UNIVERSITY   (India)

^b CU Shah College of Pharmacy   (India)

Author keywords

Enhancement in dissolution; Fenofibrate; Lyophilization; Physical mixture; Poloxamer 407; Solid dispersion; Solubility

Indexed keywords

FENOFIBRATE; MACROGOL 6000; POLOXAMER; SOLVENT;

ARTICLE; CONTROLLED STUDY; DISPERSION; DRUG SOLUBILITY; FREEZE DRYING; IN VITRO STUDY; INFRARED SPECTROSCOPY; MELTING POINT; X RAY POWDER DIFFRACTION;

EID: 77954616483     PISSN: None     EISSN: 09757538     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. A. Munoz, J.P. Guichard, P. Reginault, Micronised fenofibrate, Atherosclerosis 110 (Suppl.) (1994) S45-S48.
2. B.C. Hancock, G. Zografi, Characteristics and significance of the amorphous state in pharmaceutical systems, J. Pharm. Sci. 86 (1997) 1-12.
3. Corrigan, O.L., Mechanisms of dissolution of fast release solid dispersions. Drug Dev. Ind. Pharm., 11 (1985) 697-724.
4. G.G. Liversidge, Fenofibrate in Britain, H.G.: Analytical Profiles of Drug Substances and Excipients, vol. 22, Academic Press, New York, London, 1993, pp. 443-471.
5. G.G. Liversidge, K.C. Cundy, Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: absolute oral bioavailability of nanocrystalline danazol in beagle dogs, Int. J. Pharm. 125 (1995) 91-97.
6. J.C. Adkins, D. Faulds, Micronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidemia, Drugs 54 (1997) 615-633.
7. J.P. Guichard, P. Blouquin, Y. Qing, A new formulation of fenofibrate: suprabioavailable tablets, Curr. Med. Res. Opin. 16 (2000) 134-138.
8. J.T. Hargrove, W.S. Maxson, A.C. Wentz, Absorption of oral progesterone is influenced by vehicle and particle size, Am. J. Obstet. Gynecol. 161 (1989) 948-951.
9. Jounela, P. Pentikainen, A. Sothmann, Effect of particle size on the bioavailability of digoxin, Eur. J. Clin. Pharmacol. 8 (1975) 365-370.
10. Lin, Y.E. and Wilken, L.O. (1980) Some effects of a modified lyophilization procedure on dissolution and other properties of digoxin powders and tablets. M.S. Thesis. Auburn University, AL, p. 63.
11. M. Sugimoto, T. Okagaki, S. Narisawa, Y. Koida, K. Nakajima, Improvement of dissolution characteristics and bioavailability of poorly water-soluble drugs by novel cogrinding method using water soluble-polymer, Int. J. Pharm. 160 (1998) 11-19.
12. M.J. Grau, O. Kayser, R.H. Müller, Nanosuspensions of poorly soluble drugs reproducibility of small scale production, Int. J. Pharm. 196 (2000) 155-157.
13. MacKenzie, A.P. Principles of freeze-drying Transplant Proc., 8 (Suppl. l) (1976) 181-188.
14. Martindale, the Extra Pharmacopeia 29, Fenofibrate, Pharmaceutical Press, London, 1989, p. 25.
15. Pikal, M.J., Shah, S., Senior, D. and Lang, J.E. Physical chemistry of freeze-drying: measurement of sublimation rates for frozen aqueous solutions by a microbalance technique. J. Pharm. Sci., 72 (1983) 635-650.
16. Sekiguchi, K. and Obi, N. Studies on absorption of eutectic mixture. 1. A comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chem. Pharm. Bull., 9 (1961) 866-872.
17. Sekikawa, H., Naganuma, T., Fujiwara, J.E., Nakano, M. and Arita, T., Dissolution behaviors and gastrointes- tinal absorption of phenytoin in phenytoin-polyvinylpyrrolidone coprecipitate. Chem. Pharm. Bull., 27 (1979) 1223-1230.
18. Simonelli, A.P., Mehta, S.C. and Higuchi, W.I., Dissolution rates of high energy polyvinylpyrrolidone-sulfathiazole coprecipitates. J. Pharm. Sci., 58 (1969) 538-549.
19. T.P. Shakhtshneider, M.A. Vasiltchenko, A.A. Politov, V.V. Boldyrev, The mechanochemical preparation of solid disperse systems of ibuprofen-polyethylene Fenofibratecol, Int. J. Pharm. 130 (1996) 25-32.